The LIGHT Study

The Robinson Institute's Livebirth rate Invitro fertilisation and Growth Hormone Treatment (Light) Study is a randomised placebo controlled trial seeking to address the question of whether human growth hormone administered to patients, who have not responded well in a previous IVF cycle, improves the chance of pregnancy and livebirth in a subsequent cycle.

It is a collaborative study involving IVF units in Australia and New Zealand.

This study has been approved by each participating centres' Research Ethics Committee and the safety data form the study will be reviewed by the Data Safety and Monitoring Committee.

For more information about the research of the Robinson Institute visit our web site.